Kintor Pharmaceutical Limited
Kintor Pharmaceutical Limited (KNTPF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KNTPF · as of Jun 9, 2026
Key Statistics
Explore Kintor Pharmaceutical Limited Data
kntpf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
kntpf competitorsKNTPF
AURX
HOFBF
IPHYF
IUGNF
MSCLFStock Performance
Full HistoryAbout Kintor Pharmaceutical Limited
Kintor Pharmaceutical Limited is a clinical-stage biotechnology firm dedicated to the development and commercialization of a diverse pipeline of small molecule and biologic treatments. Its primary foc…
what is kintor pharmaceutical limited · kntpf stock overview · kintor pharmaceutical limited company profile · who is kintor pharmaceutical limited ceo · kntpf OTC · kintor pharmaceutical limited headquarters · kintor pharmaceutical limited business segments
About Stock Overview & Key Data
Kintor Pharmaceutical Limited (KNTPF) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 11, 2020. As of the latest trading session, KNTPF stock price is $0.57, with a market capitalization of $265.0M. The stock has returned +218.60% over the past 12 months and +161.67% year-to-date.
In fiscal year 2025, Kintor Pharmaceutical Limited reported revenue of $31.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kintor Pharmaceutical Limited (KNTPF) stock price is $0.57. The stock is traded on OTC under the ticker symbol KNTPF. The 52-week range is $0.18 – $0.57.